." Morgans has an add rating and a $27.50 price target on its shares. This implies potential upside of over 38% from current levels. Another ASX growth share that could have significant upside potential is sleep treatment company ResMed. The team at Citi believes that recent share price we...
View History Implied Volatility25.84% (+0.75%) Historical Volatility33.62% IV Percentile9% IV Rank9.31% IV High63.20% on 08/01/24 IV Low22.00% on 05/09/24 Put/Call Vol Ratio1.21 Today's Volume201 Volume Avg (30-Day)945 Put/Call OI Ratio3.15 ...
[of competitive bidding] there are new providers who don't have the history of ResMed or Respironics but can enter the market with lower saying effective July 1 if you use an out-of network provider your provider is going to get the price points. I've seen companies now with CPAPs 30...
The 'Upload Data to Cloud' function allows you to easily share your therapy data with your provider or physician. TEST DRIVE The Test Drive tutorial gives you a chance to try out what therapy feels like and helps troubleshoot for mask leak, so that your first night goes as smoothly as po...
Version History Nov 13, 2024 Version 3.1.0 We’re always trying to improve your experience with myAir™. This release also contains minor bug fixes and performance improvements. App Privacy The developer,ResMed, indicated that the app’s privacy practices may include handling of data as descri...
therapy progress. Simply log in to see your nightly myAir score, which shows how well you slept on therapy at a glance. Detailed metrics help you track your therapy progress over time. You can also download a therapy summary report to keep for your records or share with your healthcare ...
Version History Version 1.7.0 We’re always trying to improve your experience with AirMini™. We now support the following languages: Bulgarian, Croatian, Danish, UK English, Greek, Hungarian, Portuguese (Portugal), Romanian, Slovakian, Slovenian, Spanish (Spain) and Turkish. This release al...